BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Supporting this hypothesis is the study by Balatzenko et al. (2011) who investigated the impact of BCR‐ABL fusion types in association with multi‐drug resistance (MDR1) gene on hematological parameters in 89 Indian patients with CML.